查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
快速微生物检测市场规模、份额和成长分析（按产品、应用、方法和地区划分）—2026-2033年产业预测
市场调查报告书
商品编码
1900038

快速微生物检测市场规模、份额和成长分析（按产品、应用、方法和地区划分）—2026-2033年产业预测

Rapid Microbiology Testing Market Size, Share, and Growth Analysis, By Product (Instruments, Consumables), By Application (Clinical Disease Diagnosis, Industrial Testing), By Method, By Region -Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球快速微生物检测市场规模预计在 2024 年达到 59.4 亿美元，从 2025 年的 64.6 亿美元增长到 2033 年的 126.9 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.8%。

全球快速微生物检测市场的需求主要源自于对微生物进行近即时分析的迫切需要，而这种分析需要避免传统实验室方法耗时的流程。都市化的加速加剧了水污染，并导致包括沙​​门氏菌等病原体引起的严重感染疾病在内的多种疾病的传播。目前的检测方法在速度和准确性方面往往存在不足，凸显了对快速微生物检测解决方案的迫切需求。此外，包装食品消费量的不断增长也进一步刺激了这一需求，因为污染事件可能导致严重的公共卫生风险和代价高昂的产品召回。快速检测方法能够实现及时的微生物监测，为各行业的品管提供关键讯息，并确保食品生产和水资源管理的安全性和合规性。

推动全球快速微生物检测市场发展的因素

感染疾病（尤其是医院感染）发生率的上升以及抗生素抗药性问题的日益严峻，正显着推动全球对快速微生物检测的需求。政府和私营部门都在增加对医疗保健的投资，尤其是在新兴市场，这使得建立先进的诊断能力以有效应对感染疾病疫情成为当务之急。此外，人们越来越认识到早期诊断的准确性对于改善患者预后至关重要。这些因素共同推动着创新微生物解决方案在全球范围内的广泛应用。

全球快速微生物检测市场限制因素

全球快速微生物检测市场面临许多限制因素，其中最主要的是部署和维护先进检测设备的高成本。许多实验室和医疗机构，尤其是在低收入和发展中地区，都难以承担这些先进系统带来的经济负担，包括初始投资和持续的基础设施维护成本。因此，预算有限的小规模实验室和医院往往难以从传统诊断方法过渡到更有效率的快速微生物检测解决方案。这种经济限制因素严重阻碍了快速微生物检测市场的成长和普及。

全球快速微生物检测市场趋势

全球快速微生物检测市场正经历一场由人工智慧 (AI) 和巨量资料分析融合驱动的重大变革，预示着诊断效率的新纪元。人工智慧解决方案显着提升了快速处理和分析大量资料集的能力，从而在微生物检测中提供更快、更准确的结果。这项技术进步赋予了医疗专业人员预测模型，使其能够预见感染疾病爆发并制定有效的预防措施。因此，这项创新不仅改善了患者照护，还优化了临床资源配置，使快速微生物检测成为现代医学进步的前沿技术。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2025）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究
  • 监管环境
  • 专利分析

全球快速微生物检测市场规模（按产品和复合年增长率划分）（2026-2033 年）

  • 装置
  • 试剂和试剂盒
  • 消耗品

全球快速微生物检测市场规模（按方法和复合年增长率划分）（2026-2033 年）

  • 基于生长的快速微生物检测
  • 快速细胞微生物检测
  • 基于核酸的快速微生物检测
  • 基于活性的快速微生物检测

全球快速微生物检测市场规模（按应用领域及复合年增长率划分）（2026-2033 年）

  • 临床疾病诊断
  • 食品和饮料检查
  • 药物和生物技术检测
  • 环境检查
  • 研究用途

全球快速微生物检测市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

  • 医院和诊断检查室
  • 製药和生物技术公司
  • 受託研究机构（CRO）
  • 学术研究机构
  • 食品和饮料公司

全球快速微生物检测市场规模及复合年增长率（2026-2033）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Becton, Dickinson and Company（USA）
  • bioMerieux SA（France）
  • Danaher Corporation（USA）
  • Abbott Laboratories（USA）
  • Thermo Fisher Scientific Inc.（USA）
  • Merck KGaA（Germany）
  • Sartorius AG（Germany）
  • Bruker Corporation（USA）
  • QuidelOrtho Corporation（USA）
  • Charles River Laboratories（USA）
  • Neogen Corporation（USA）
  • Don Whitley Scientific Limited（UK）
  • Rapid Micro Biosystems, Inc.（USA）
  • Gradientech（Sweden）
  • rqmicro AG（Switzerland）
  • Colifast AS（Norway）
  • Serosep Limited（Ireland）
  • Solus PerkinElmer（USA）
  • BTNX Inc.（Canada）
  • R-Biopharm AG（Germany）

结论与建议

简介目录
Product Code: SQMIG35A2782

Global Rapid Microbiology Testing Market size was valued at USD 5.94 Billion in 2024 and is poised to grow from USD 6.46 Billion in 2025 to USD 12.69 Billion by 2033, growing at a CAGR of 8.8% during the forecast period (2026-2033).

The global market for rapid microbiology testing is driven by the urgent need for near real-time analysis of microorganisms without the lengthy processes associated with traditional lab methods. Increasing urbanization has exacerbated water pollution, contributing to widespread diseases, including significant infections caused by pathogens like Salmonella. Current detection methods often fall short in speed and accuracy, highlighting the critical demand for rapid microbiology solutions. Furthermore, the rising consumption of packaged foods amplifies this need, as incidents of contamination can lead to severe public health risks and costly recalls. Rapid testing methods enable timely microbial monitoring, providing essential insights for maintaining quality control across various sectors, ensuring safety and compliance in food production and water management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Rapid Microbiology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Rapid Microbiology Testing Market Segments Analysis

Global Rapid Microbiology Testing Market is segmented by Product, Method, Application, End User and region. Based on Product, the market is segmented into Instruments, Reagents and Kits and Consumables. Based on Method, the market is segmented into Growth-Based Rapid Microbiology Testing, Cellular Component-Based Rapid Microbiology Testing, Nucleic Acid-Based Rapid Microbiology Testing and Viability-Based Rapid Microbiology Testing. Based on Application, the market is segmented into Clinical Disease Diagnostics, Food and Beverage Testing, Pharmaceutical and Biotechnology Testing, Environmental Testing and Research Applications. Based on End User, the market is segmented into Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutes and Food and Beverage Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Rapid Microbiology Testing Market

The escalating incidence of infectious diseases, particularly hospital-acquired infections and the growing challenges of antibiotic resistance, has spurred a significant demand for rapid microbiology testing worldwide. Enhanced investments in healthcare, particularly in emerging markets, are being driven by both governmental and private sectors, which are prioritizing the establishment of advanced diagnostic capabilities to effectively address outbreaks. Furthermore, there is a heightened awareness of the importance of early diagnostic precision, which is crucial for improving patient outcomes. This combination of factors is fostering the widespread adoption of innovative microbiological solutions across the globe.

Restraints in the Global Rapid Microbiology Testing Market

The Global Rapid Microbiology Testing market faces significant constraints due to the high costs associated with acquiring and maintaining advanced testing equipment. Many laboratories and healthcare facilities, particularly in low-income and underdeveloped areas, struggle with the financial burden of these sophisticated systems, which includes both initial investment and ongoing infrastructure maintenance expenses. As a result, smaller laboratories and hospitals, constrained by their budgets, often find it challenging to transition from traditional diagnostic methods to more efficient rapid microbiological solutions. This financial limitation significantly hampers the growth and adoption of rapid microbiological testing across the market.

Market Trends of the Global Rapid Microbiology Testing Market

The Global Rapid Microbiology Testing market is experiencing a significant transformation driven by the integration of artificial intelligence (AI) and big data analytics, heralding a new era in diagnostic efficacy. AI-powered solutions are enhancing the ability to process and analyze vast datasets swiftly, yielding quicker and more precise outcomes for microbial assessments. This technological advancement also empowers healthcare professionals with predictive modeling, enabling them to foresee infection outbreaks and tailor preventive measures effectively. Consequently, this innovation is not only improving patient care but also optimizing resource allocation in clinical settings, positioning rapid microbiological testing at the forefront of modern healthcare advancements.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Patent Analysis

Global Rapid Microbiology Testing Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Instruments
  • Reagents and Kits
  • Consumables

Global Rapid Microbiology Testing Market Size by Method & CAGR (2026-2033)

  • Market Overview
  • Growth-Based Rapid Microbiology Testing
  • Cellular Component-Based Rapid Microbiology Testing
  • Nucleic Acid-Based Rapid Microbiology Testing
  • Viability-Based Rapid Microbiology Testing

Global Rapid Microbiology Testing Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Clinical Disease Diagnostics
  • Food and Beverage Testing
  • Pharmaceutical and Biotechnology Testing
  • Environmental Testing
  • Research Applications

Global Rapid Microbiology Testing Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals and Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Food and Beverage Companies

Global Rapid Microbiology Testing Market Size & CAGR (2026-2033)

  • North America (Product, Method, Application, End User)
    • US
    • Canada
  • Europe (Product, Method, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Method, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Method, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Method, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QuidelOrtho Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neogen Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Don Whitley Scientific Limited (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rapid Micro Biosystems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gradientech (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • rqmicro AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Colifast AS (Norway)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Serosep Limited (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Solus PerkinElmer (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BTNX Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • R-Biopharm AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations